OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation
Chandran Remya, K.V. Dileep, Eeda Koti Reddy, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4517-4537
Open Access | Times Cited: 24

Showing 24 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 613

Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition
Anna Misiachna, Barbora Svobodová, Jakub Netolický, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116130-116130
Open Access | Times Cited: 8

Structural, harmonic force field and vibrational studies of cholinesterase inhibitor tacrine used for treatment of Alzheimer's disease
Tom Sundius, Silvia Antonia Brandán
Heliyon (2023) Vol. 9, Iss. 6, pp. e17280-e17280
Open Access | Times Cited: 18

Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 16

The complex interplay between ligand strain, coulombic interactions, and binding site dynamics of two congeneric AChE inhibitors
Aravinda Babu, Chandran Remya, Ayyiliyath M. Sajith, et al.
Journal of Molecular Structure (2025), pp. 141479-141479
Closed Access

Unraveling the Therapeutic Potential of Alzheimer’s Drugs: A Comprehensive Review
Anjali Rani, Javed Khan, Lakshika Choudhary, et al.
Tetrahedron (2025), pp. 134517-134517
Closed Access

Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential
Saikat Mitra, Maniza Muni, Nusrat Jahan Shawon, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 26

Role of Ca2+/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses
Archana G. Mohanan, Sowmya Gunasekaran, Reena Sarah Jacob, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 23

An insight into prodrug strategy for the treatment of Alzheimer’s disease
Neha V. Bhilare, Vinayak S. Marulkar, Dileep Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 3, pp. 383-399
Closed Access | Times Cited: 17

Ginkgolic acid inhibited Tau phosphorylation and improved cognitive ability through the SUMO-1/GSK3β pathway in Aβ-Induced Alzheimer’s disease model rats
Kun Chen, Ruiqing Shi, Pengkai Huang, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106183-106183
Open Access | Times Cited: 2

Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 7

Sub-pocket-focused designing of tacrine derivatives as potential acetylcholinesterase inhibitors
Aravinda Babu, Mathew John, M. J. Liji, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106666-106666
Closed Access | Times Cited: 7

Towards novel tacrine analogues: Pd(dppf)Cl2·CH2Cl2 catalyzed improved synthesis, in silico docking and hepatotoxicity studies
Aravinda Babu, Muthipeedika Nibin Joy, K. Sunil, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22476-22491
Open Access | Times Cited: 8

Mechanistic Study of Xanthotoxin-Mediated Inactivation of CYP1A2 and Related Drug–Drug Interaction with Tacrine
Guangyun Ran, Yufen Liao, Xin Wang, et al.
Chemical Research in Toxicology (2023) Vol. 36, Iss. 3, pp. 420-429
Closed Access | Times Cited: 4

Lobeline: A multifunctional alkaloid modulates cholinergic and glutamatergic activities
Chandran Remya, K.V. Dileep, E. Jayadevi Variyar, et al.
IUBMB Life (2023) Vol. 75, Iss. 10, pp. 844-855
Closed Access | Times Cited: 4

Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114701-114701
Closed Access | Times Cited: 7

Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease
Cem Yamalı, Şeyda Dönmez
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 869-880
Closed Access | Times Cited: 6

Novel Chromone-Containing Allylmorpholines Induce Anxiolytic-like and Sedative Effects in Adult Zebrafish
V. A. Prikhodko, Yuri I. Sysoev, Elena Gerasimova, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2783-2783
Open Access | Times Cited: 2

Phenoxytacrine Derivatives: Low-Toxicity Neuroprotectants Exerting Affinity to Ifenprodil-Binding Site and Cholinesterase Inhibition
Anna Misiachna, Barbora Svobodová, Jakub Netolický, et al.
SSRN Electronic Journal (2023)
Closed Access

Virtual screening of lead compounds for the treatment of Alzheimer’s disease based on multi-target strategy
Ruoyu Li, Jiali Xie, Dan Meng, et al.
Molecular Simulation (2022) Vol. 48, Iss. 17, pp. 1533-1547
Closed Access

Page 1

Scroll to top